13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 72 holding rows worth $2,722,670,757.
- Accession
- 0001420506-24-000478
- Filer
- CIK 1920938
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 72 entries on the cover page, a total value of $2,722,670,757 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,722,670,757 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 268,252,000 | $189,117,660 | dollars as filed | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 114,338,000 | $138,406,149 | dollars as filed | principal |
| Ascendis Pharma A/S | 04351PAD3 | Convertible bond | 126,897,000 | $130,386,668 | dollars as filed | principal |
| EXACT SCIENCES CORP | 30063PAC9 | NOTE 0.375% 3/0 | 131,000,000 | $123,140,000 | dollars as filed | principal |
| NOVOCURE LTD | 67011XAB9 | NOTE 11/0 | 135,834,000 | $117,917,495 | dollars as filed | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 715,209 | $94,235,938 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,289,965 | $81,009,802 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,647,311 | $75,875,145 | dollars as filed | |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 80,530,000 | $74,288,925 | dollars as filed | principal |
| INSULET CORP | 45784PAK7 | NOTE 0.375% 9/0 | 63,000,000 | $72,702,000 | dollars as filed | principal |
| TANDEM DIABETES CARE INC | 875372AB0 | NOTE 1.500% 5/0 | 71,051,000 | $67,178,721 | dollars as filed | principal |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 4,215,573 | $61,547,366 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 568,157 | $60,815,525 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 153,204 | $58,283,398 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 67,294,000 | $57,327,759 | dollars as filed | principal |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 52,388,000 | $56,123,264 | dollars as filed | principal |
| PENUMBRA INC COM | 70975L107 | Stock | 222,792 | $56,041,100 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607AD2 | NOTE 1.250% 9/1 | 50,666,000 | $51,522,255 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 65,601,000 | $50,199,537 | dollars as filed | principal |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 56,031,000 | $47,699,190 | dollars as filed | principal |
| DEXCOM INC | 252131AK3 | NOTE 0.250%11/1 | 45,000,000 | $47,205,000 | dollars as filed | principal |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,118,961 | $44,489,889 | dollars as filed | |
| PARAGON 28 INC | 69913P105 | COM | 3,361,824 | $41,787,472 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 611,365 | $41,768,457 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 75,749 | $40,206,812 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 146,313 | $40,089,762 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333XAF5 | BOND | 37,509,000 | $39,478,223 | dollars as filed | principal |
| NEVRO CORP | 64157F103 | COM | 1,776,368 | $38,227,439 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 184,658 | $37,564,977 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,107,770 | $36,013,603 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 5,718,477 | $34,253,677 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 562,600 | $33,851,642 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 5,040,635 | $33,016,159 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 65,976,000 | $32,987,982 | dollars as filed | principal |
| LANTHEUS HLDGS INC | 516544103 | COM | 495,100 | $30,696,200 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 26,750,000 | $28,368,375 | dollars as filed | principal |
| ALECTOR INC | 014442107 | COMMON STOCK | 3,324,308 | $26,527,978 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 196,200 | $24,340,572 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 906,820 | $23,740,548 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 758,928 | $20,529,002 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 242,760 | $19,296,992 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 681,101 | $19,029,962 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,169,490 | $18,863,874 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 102,698 | $18,465,100 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 2,023,900 | $17,405,540 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333XAH1 | NOTE 1.500% 6/1 | 15,500,000 | $16,871,750 | dollars as filed | principal |
| HARROW INC | 415858109 | COM | 1,498,584 | $16,784,141 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 58,200 | $16,762,764 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 2,318,050 | $15,044,145 | dollars as filed | |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 16,781,000 | $14,850,554 | dollars as filed | principal |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,316,018 | $14,436,717 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 2,400,427 | $12,986,310 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,240,865 | $12,644,414 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 280,158 | $11,419,240 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 16,850,000 | $11,121,000 | dollars as filed | principal |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 515,000 | $11,082,800 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 370,679 | $10,193,673 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 755,811 | $10,052,286 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 787,954 | $10,046,414 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 461,769 | $9,909,563 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 389,300 | $9,674,105 | dollars as filed | |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 10,000,000 | $9,375,000 | dollars as filed | principal |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 117,701 | $9,290,140 | dollars as filed | |
| CUTERA INC | 232109AD0 | NOTE 2.250% 6/0 | 31,900,000 | $8,373,750 | dollars as filed | principal |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 7,843,285 | $7,473,082 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 323,102 | $7,037,162 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 1,357,490 | $6,651,701 | dollars as filed | |
| CUTERA INC | 232109AG3 | NOTE 4.000% 6/0 | 29,000,000 | $6,543,125 | dollars as filed | principal |
| IONIS PHARMACEUTICALS INC | 462222AD2 | NOTE 4/0 | 5,240,000 | $5,538,680 | dollars as filed | principal |
| HILLEVAX INC | 43157M102 | COM | 203,407 | $3,264,682 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 3,650,000 | $2,724,718 | dollars as filed | principal |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 317,761 | $495,707 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000478 | this filing | 2024-02-14 | acceptance time not in the bulk data set |